Boinapally et al. developed small-molecule PSMA- and FAP-targeting moieties with 64Cu, named 64Cu-FP-L1 and 64Cu-FP-L2, respectively 116, with the potential to be used for PSMA-FAP dual-targeted guided PCa surgery. Here, FAP is linked to posterior cortical atrophy.